1. Home
  2. PTCT vs MTDR Comparison

PTCT vs MTDR Comparison

Compare PTCT & MTDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • MTDR
  • Stock Information
  • Founded
  • PTCT 1998
  • MTDR 2003
  • Country
  • PTCT United States
  • MTDR United States
  • Employees
  • PTCT N/A
  • MTDR N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • MTDR Oil & Gas Production
  • Sector
  • PTCT Health Care
  • MTDR Energy
  • Exchange
  • PTCT Nasdaq
  • MTDR Nasdaq
  • Market Cap
  • PTCT 5.3B
  • MTDR 5.4B
  • IPO Year
  • PTCT 2013
  • MTDR 2012
  • Fundamental
  • Price
  • PTCT $75.70
  • MTDR $41.43
  • Analyst Decision
  • PTCT Buy
  • MTDR Buy
  • Analyst Count
  • PTCT 17
  • MTDR 15
  • Target Price
  • PTCT $73.24
  • MTDR $62.79
  • AVG Volume (30 Days)
  • PTCT 1.1M
  • MTDR 2.6M
  • Earning Date
  • PTCT 11-04-2025
  • MTDR 10-21-2025
  • Dividend Yield
  • PTCT N/A
  • MTDR 3.62%
  • EPS Growth
  • PTCT N/A
  • MTDR N/A
  • EPS
  • PTCT 8.94
  • MTDR 6.24
  • Revenue
  • PTCT $1,779,150,000.00
  • MTDR $3,556,751,000.00
  • Revenue This Year
  • PTCT $119.02
  • MTDR $14.61
  • Revenue Next Year
  • PTCT N/A
  • MTDR $1.29
  • P/E Ratio
  • PTCT $8.42
  • MTDR $6.64
  • Revenue Growth
  • PTCT 97.54
  • MTDR 14.75
  • 52 Week Low
  • PTCT $35.95
  • MTDR $35.19
  • 52 Week High
  • PTCT $76.80
  • MTDR $64.05
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 79.67
  • MTDR 51.81
  • Support Level
  • PTCT $69.23
  • MTDR $39.70
  • Resistance Level
  • PTCT $73.98
  • MTDR $40.93
  • Average True Range (ATR)
  • PTCT 2.67
  • MTDR 1.21
  • MACD
  • PTCT 0.40
  • MTDR 0.48
  • Stochastic Oscillator
  • PTCT 89.08
  • MTDR 99.08

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About MTDR Matador Resources Company

Matador Resources Co is an independent energy company engaged in the exploration, development, production, and acquisition of oil and natural gas resources. The majority of the company's assets are located in the United States, with an emphasis on oil and natural gas shale and other unconventional plays. Along with maintaining a portfolio of oil and natural gas properties, Matador works to identify and develop midstream opportunities that support and enhance its exploration and development business. The Company has two reportable business segments: exploration and production and midstream.

Share on Social Networks: